Gro Biosciences announced it raised $27.4 Million in an initial filing from an offering of $60.4 Million

Company

Location

About

GRO Biosciences is an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics. The company is transforming treatments in diverse areas including autoimmune and metabolic diseases to improve the lives of patients. GRO Biosciences is applying its platform to advance partnered and collaborative programs, as well as its own pipeline of protein therapeutics bearing unique non-standard amino acid (NSAA) chemistries.